CML-423 Trial in Progress: A Phase III Study of Asciminib vs an Investigator-Selected Tyrosine Kinase Inhibitor (TKI) in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP)

Authors :: Timothy P. Hughes
Jorge Cortes
Naoto Takahashi
Richard Larson
Ghayas C. Issa
Felice Bombaci
Nicholas Ramscar
Shruti Kapoor
Sophie Ifrah
Andreas Hochhaus
Source :: Clinical Lymphoma Myeloma and Leukemia. 22:S297-S298
Publication Year :: 2022
Publisher :: Elsevier BV, 2022.

Tools